Advances in Alzheimer’s Disease
June 1, 2017
By Gail Rosenblum – Advances are being made globally in the area of Alzheimer’s disease and related dementia disorders, and Bench International has been privileged to work extensively in this field, partnering most recently with Chase Pharmaceuticals, Axovant Sciences and Bionomics Limited.
Designated in 1983 by then – President Ronald Reagan, November marks National Alzheimer’s Disease Awareness Month – is also a chance to celebrate all of the progress in Alzheimer’s research and the development of treatments for this devastating disease.